Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dae Hwa Pharm Co Ltd to Acquire Korea-based Company


Wednesday, 31 Jul 2013 03:33am EDT 

Dae Hwa Pharm Co Ltd announced that it will acquire 93,600 shares of a Korea-based company, which is mainly engaged in the manufacturing of medicine, for KRW 1,085,760,000, to improve corporation competitiveness and synergy. The expected transaction settlement date is August 22, 2013. After the transaction, the Company will hold 93,600 shares, or 100% of the Korea-based company. 

Company Quote

6560.0
-10.0 -0.15%
9:36pm EDT